COL25A1

COL25A1

Target · Membrane collagen

COL25A1 Collagen type XXV alpha 1 chain · Collagen alpha-1(XXV) chain

COL25A1 (collagen type XXV alpha 1 chain) encodes a brain-specific, membrane-associated collagen. Its proteolytic product, CLAC (collagenous Alzheimer amyloid plaque component), binds amyloid-beta peptides and is a focus of Alzheimer's disease research. Browse Assay Genie's current range of COL25A1 research reagents below, or read on for the biology behind the target.

Membrane-associated collagenBinds amyloid-beta and heparinBrain-specific expression
654 aa
Protein length
~65 kDa
Molecular weight
4q25
Gene locus
Membrane collagen
Protein family
Target information

What is COL25A1 (collagen type XXV alpha 1 chain)?

COL25A1 is a membrane-associated collagen. According to UniProt, the protein inhibits fibrillization of amyloid-beta peptide during the elongation phase, and has also been shown to assemble amyloid fibrils into protease-resistant aggregates. It also binds heparin. These properties link the protein directly to the biology of amyloid deposition.

The COL25A1 gene encodes a brain-specific collagen and belongs to the HGNC gene group of membrane associated collagens with interrupted triple helices. Multiple transcript variants encoding different isoforms have been reported for the gene. The mouse ortholog is Col25a1, which has been used in over-expression studies.

A product of proteolytic processing of the encoded protein, CLAC (collagenous Alzheimer amyloid plaque component), binds amyloid-beta peptides found in Alzheimer amyloid plaques. In vitro, CLAC inhibits rather than facilitates amyloid fibril elongation. However, a study of over-expression of this collagen in mice found changes in pathology and behaviour suggesting that the protein may instead promote amyloid plaque formation. The role of COL25A1 in plaque biology therefore remains an active question. The previous HGNC name for the gene was collagen, type XXV, alpha 1.

Alzheimer's disease research

CLAC, derived from COL25A1, binds amyloid-beta in Alzheimer amyloid plaques, making the protein relevant to studies of plaque composition.

Amyloid fibril formation

COL25A1 inhibits amyloid-beta fibril elongation and can assemble fibrils into protease-resistant aggregates, so it is used to study aggregation mechanisms.

Neurobiology

As a brain-specific membrane collagen, COL25A1 is of interest for studying collagen function in the nervous system.

Collagen proteolytic processing

CLAC is a proteolytic product of the encoded protein, which makes COL25A1 a model for processing of membrane-associated collagens.

Background

COL25A1 frequently asked questions

What does COL25A1 do?

COL25A1 encodes a brain-specific membrane-associated collagen. UniProt reports that it inhibits amyloid-beta fibrillization during the elongation phase, can assemble amyloid fibrils into protease-resistant aggregates, and binds heparin. Its processed product CLAC binds amyloid-beta in Alzheimer amyloid plaques.

What is CLAC and how does it relate to COL25A1?

CLAC stands for collagenous Alzheimer amyloid plaque component. It is a product of proteolytic processing of the COL25A1-encoded protein. CLAC binds amyloid-beta peptides in Alzheimer amyloid plaques. The gene also has multiple transcript variants encoding different isoforms.

Is COL25A1 conserved in other species, and is it linked to disease?

A mouse ortholog, Col25a1, exists, and over-expression in mice altered pathology and behaviour, suggesting a possible role in promoting amyloid plaque formation. The protein is linked to Alzheimer's disease research through CLAC. Check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other membrane-associated and extracellular matrix collagens with products at Assay Genie.

Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9BXS0; product specifications from Assay Genie datasheets.

COL25A1 Product listing

There are no products listed under this category.